Pandey Swadha, Gupta Saurabh, Bharadwaj Alok, Rastogi Amisha
Department of Biotechnology, GLA University, Mathura, Uttar Pradesh 281406 India.
Sapien Biosciences, Apollo Health City, Hyderabad, Telangana 500096 India.
Indian J Microbiol. 2025 Mar;65(1):189-203. doi: 10.1007/s12088-024-01296-5. Epub 2024 May 27.
Microfluidics has advanced the area of diagnostics during the past ten years by offering fresh approaches that weren't achievable with traditional detection and treatment techniques. High-throughput operations can be carefully controlled by using microfluidics and are very cost-effective too. It has been accepted to be a quick and effective method for controlled medication delivery, biological sample preparation, and analysis. This new technology has made it possible to create a wide range of micro and nanocarriers for poorly soluble medications, which has many advantages over traditional drug delivery techniques. Furthermore, a targeted medication delivery system utilizing microfluidic technology can be developed to enhance the drug's local bioavailability. Over the years, extensive R&D in microfluidic technology has led to the creation of various advanced applications in both laboratory and consumer biotechnology. Miniaturized genetic and proteasome analyzers, cell culture and control platforms, biosensors, disease detection, optical imaging devices, diagnostic advanced drugs, drug delivery schemes, and innovative products are some of the advanced applications of the microfluidics system. Also, these are highly adaptable microfluidic tools for disease detection and organ modeling, as well as transduction devices used in biomedical applications to detect biological and chemical changes. Beyond the specialized difficulties in studying cell-cell interactions, microfluidics has several difficulties in biomedical applications, especially for diagnostic devices where minute interactions can lead to imprecise evaluations. Assay function can be significantly changed by the way plastics, adhesives, and other materials interact. Therefore, the foundation of microfluidic technology needs to be grounded in real-world uses that can be produced on a big scale and at a reasonable cost. Further, it is a very interdisciplinary field that requires the collaboration of professionals in fluidics, assay science, materials science, and instrumentation to provide devices with the proper and needed functionality. In this article, we have discussed the advanced disease diagnosis and their therapeutic management which will help to understand the current scenario in the field of microfluidics diagnosis and will fill knowledge about the 'gap' in the system.
在过去十年中,微流控技术通过提供传统检测和治疗技术无法实现的全新方法,推动了诊断领域的发展。利用微流控技术可以精确控制高通量操作,而且成本效益非常高。它已被公认为是一种用于可控药物递送、生物样品制备和分析的快速有效方法。这项新技术使得为难溶性药物创建各种微纳米载体成为可能,与传统药物递送技术相比具有许多优势。此外,可以开发利用微流控技术的靶向药物递送系统,以提高药物的局部生物利用度。多年来,微流控技术的广泛研发催生了实验室和消费生物技术领域的各种先进应用。微型基因和蛋白酶体分析仪、细胞培养和控制平台、生物传感器、疾病检测、光学成像设备、诊断性先进药物、药物递送方案以及创新产品等都是微流控系统的一些先进应用。而且,这些是用于疾病检测和器官建模的高度适应性微流控工具,以及用于生物医学应用中检测生物和化学变化的转导设备。除了研究细胞间相互作用存在的特殊困难外,微流控技术在生物医学应用中还存在一些困难,特别是对于诊断设备而言,微小的相互作用可能导致评估不准确。塑料、粘合剂和其他材料的相互作用方式会显著改变检测功能。因此,微流控技术的基础需要建立在能够大规模且以合理成本生产的实际应用之上。此外,这是一个非常跨学科的领域,需要流体学、检测科学、材料科学和仪器仪表专业人员的协作,以提供具有适当和所需功能的设备。在本文中,我们讨论了先进的疾病诊断及其治疗管理,这将有助于了解微流控诊断领域的当前情况,并填补对该系统“差距”的认识。